Results SUPN Trades

Show
Results

Buy and Hold Total Return:  317.21% Buy and Hold Average Win:  317.21 Buy and Hold Average Loss:  ******** Buy and Hold Number of Wins: 3Buy and Hold Number of Losses: 0Trading System Total Return:  0.49% Trading System Number of Wins: 2.00Trading System Number of Losses: 1.00Start Date: 09/17/13

Show Chart

Show Trade

Supernus Pharmaceuticals, Inc. - Symbol: SUPN  (Exchange: NASD)

Buy and Hold

On 09/22/17 generated a Bearish MA Crossover Opportunities signal at the entry price of 39.00. After 502 days, the latest closing price is 38.38. The current return for Supernus Pharmaceuticals, Inc. is 1.59%. It is currently a winning trade. After two weeks of trading, Supernus Pharmaceuticals, Inc. had returned -5.51% on investment. After a month, -6.15%. After two months, -0.13%. 

Trading System Results

The trade is currently closed. Supernus Pharmaceuticals, Inc. was a -5.38% loss.

Show Chart

Show Trade

Supernus Pharmaceuticals, Inc. - Symbol: SUPN  (Exchange: NASD)

Buy and Hold

On 09/19/13 generated a Bullish MACD Opportunities signal at the entry price of 6.87. After 1966 days, the latest closing price is 38.38. The current return for Supernus Pharmaceuticals, Inc. is 458.66%. It is currently a winning trade. After two weeks of trading, Supernus Pharmaceuticals, Inc. had returned 4.51% on investment. After a month, -2.62%. After two months, 1.16%. 

Trading System Results

The trade is currently closed. Supernus Pharmaceuticals, Inc. was a 2.33% gain.

Show Chart

Show Trade

Supernus Pharmaceuticals, Inc. - Symbol: SUPN  (Exchange: NASD)

Buy and Hold

On 09/17/13 generated a Bullish MA Crossover Opportunities signal at the entry price of 6.49. After 1968 days, the latest closing price is 38.38. The current return for Supernus Pharmaceuticals, Inc. is 491.37%. It is currently a winning trade. After two weeks of trading, Supernus Pharmaceuticals, Inc. had returned 9.40% on investment. After a month, 3.08%.

Trading System Results

The trade is currently closed. Supernus Pharmaceuticals, Inc. was a 3.54% gain.